|
1
|
Li JS, Touyz RM and Schiffrin EL: Effects
of AT1 and AT2 angiotensin receptor antagonists in angiotensin
II-infused rats. Hypertension. 31:487–492. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Griendling KK and Ushio-Fukai M: Reactive
oxygen species as mediators of angiotensin II signaling. Regul
Pept. 91:21–27. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang H, Schmeisser A, Garlichs CD, Plötze
K, Damme U, Mügge A and Daniel WG: Angiotensin II-induced
superoxide anion generation in human vascular endothelial cells:
Role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res.
44:215–222. 1999. View Article : Google Scholar
|
|
4
|
Ruiz-Ortega M, Lorenzo O, Ruperez M, König
S, Wittig B and Egido J: Angiotensin II activates nuclear
transcription factor kappaB through AT(1) and AT(2) in vascular
smooth muscle cells: Molecular mechanisms. Circ Res. 86:1266–1272.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marshall RP, Gohlke P, Chambers RC, Howell
DC, Bottoms SE, Unger T, McAnulty RJ and Laurent GJ: Angiotensin II
and the fibroproliferative response to acute lung injury. Am J
Physiol Lung Cell Mol Physiol. 286:L156–L164. 2004. View Article : Google Scholar
|
|
6
|
Marshall RP, McAnulty RJ and Laurent GJ:
Angiotensin II is mitogenic for human lung fibroblasts via
activation of the type 1 receptor. Am J Respir Crit Care Med.
161:1999–2004. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bechara RI, Pelaez A, Palacio A, Joshi PC,
Hart CM, Brown LA, Raynor R and Guidot DM: Angiotensin II mediates
glutathione depletion, transforming growth factor-beta1 expression
and epithelial barrier dysfunction in the alcoholic rat lung. Am J
Physiol Lung Cell Mol Physiol. 289:L363–L370. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan
B, Yang P, Sarao R, Wada T, Leong-Poi H, et al:
Angiotensin-converting enzyme 2 protects from severe acute lung
failure. Nature. 436:112–116. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Idell S, Kueppers F, Lippmann M, Rosen H,
Niederman M and Fein A: Angiotensin converting enzyme in
bronchoalveolar lavage in ARDS. Chest. 91:52–56. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brasier AR, Recinos A III and Eledrisi MS:
Vascular inflammation and the renin-angiotensin system.
Arterioscler Thromb Vasc Biol. 22:1257–1266. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Masaki H, Kurihara T, Yamaki A, Inomata N,
Nozawa Y, Mori Y, Murasawa S, Kizima K, Maruyama K, Horiuchi M, et
al: Cardiac-specific overexpression of angiotensin II AT2 receptor
causes attenuated response to AT1 receptor-mediated pressor and
chronotropic effects. J Clin Invest. 101:527–535. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang H and Sun GY: Expression and
regulation of AT1 receptor in rat lung microvascular endothelial
cell. J Surg Res. 134:190–197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Garcia JG, Liu F, Verin AD, Birukova A,
Dechert MA, Gerthoffer WT, Bamberg JR and English D: Sphingosine
1-phosphate promotes endothelial cell barrier integrity by
Edg-dependent cytoskeletal rearrangement. J Clin Invest.
108:689–701. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Birukova AA, Wu T, Tian Y, Meliton A,
Sarich N, Tian X, Leff A and Birukov KG: Iloprost improves
endothelial barrier function in lipopolysaccharide-induced lung
injury. Eur Respir J. 41:165–176. 2013. View Article : Google Scholar :
|
|
15
|
Li H, Qiu H, Xu D, Liu L, Wang L, Dig H,
Yang Y and Zhou S: Establishment of radioligand binding assay for
angiotensin II type 1 receptor of human pulmonary microvascular
endothelial cell after lipopolysaccharide stimulation. Int J
Respir. 27:1761–1764. 2007.
|
|
16
|
Dincer HE, Gangopadhyay N, Wang R and Uhal
BD: Norepinephrine induces alveolar epithelial apoptosis mediated
by alpha-, beta- and angiotensin receptor activation. Am J Physiol
Lung Cell Mol Physiol. 281:L624–L630. 2001.PubMed/NCBI
|
|
17
|
Li X, Shu R, Filippatos G and Uhal BD:
Apoptosis in lung injury and remodeling. J Appl Physiol (1985).
97:1535–1542. 2004. View Article : Google Scholar
|
|
18
|
Chan LY, Leung JC, Tang SC, Choy CB and
Lai KN: Tubular expression of angiotensin II receptors and their
regulation in IgA nephropathy. J Am Soc Nephrol. 16:2306–2317.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li JY, Avallet O, Berthelon MC, Langlois D
and Saez JM: Transcriptional and translational regulation of
angiotensin II type 2 receptor by angiotensin II and growth
factors. Endocrinology. 140:4988–4994. 1999.PubMed/NCBI
|
|
20
|
Raiden S, Nahmod K, Nahmod V, Semeniuk G,
Pereira Y, Alvarez C, Giordano M and Geffner JR: Nonpeptide
antagonists of AT1 receptor for angiotensin II delay the onset of
acute respiratory distress syndrome. J Pharmacol Exp Ther.
303:45–51. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sasamura H, Nakazato Y, Hayashida T,
Kitamura Y, Hayashi M and Saruta T: Regulation of vascular type 1
angiotensin receptors by cytokines. Hypertension. 30:35–41. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li D, Yang B, Philips MI and Mehta JL:
Proapoptotic effects of ANG II in human coronary artery endothelial
cells: Role of AT1 receptor and PKC activation. Am J Physiol.
276:H786–H792. 1999.PubMed/NCBI
|
|
23
|
Trowbridge IS, Collawn JF and Hopkins CR:
Signal-dependent membrane protein trafficking in the endocytic
pathway. Annu Rev Cell Biol. 9:129–161. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mukherjee S, Ghosh RN and Maxfield FR:
Endocytosis. Physiol Rev. 77:759–803. 1997.PubMed/NCBI
|
|
25
|
Marsh M and McMahon HT: The structural era
of endocytosis. Science. 285:215–220. 1999. View Article : Google Scholar : PubMed/NCBI
|
